GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » The Joint Corp (NAS:JYNT) » Definitions » Graham Number

The Joint (The Joint) Graham Number : $N/A (As of Dec. 2023)


View and export this data going back to 2014. Start your Free Trial

What is The Joint Graham Number?

Graham Number is a figure that measures a stock's fundamental value by taking into account the company's earnings per share and book value per share. The Graham number is the upper bound of the price range that a defensive investor should pay for the stock. According to the theory, any stock price below the Graham number is considered undervalued, and thus worth investing in.

As of today (2024-04-28), the stock price of The Joint is $12.23. The Joint's graham number for the quarter that ended in Dec. 2023 was $N/A. Therefore, The Joint's Price to Graham Number ratio for today is N/A.

The historical rank and industry rank for The Joint's Graham Number or its related term are showing as below:

During the past 12 years, the highest Price to Graham Number ratio of The Joint was 16.26. The lowest was 5.95. And the median was 12.16.

JYNT's Price-to-Graham-Number is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 2.075
* Ranked among companies with meaningful Price-to-Graham-Number only.

Graham Number is a combination of asset valuation and earnings power valuation. It is a very conservative way of valuing a stock.


The Joint Graham Number Historical Data

The historical data trend for The Joint's Graham Number can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

The Joint Graham Number Chart

The Joint Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Graham Number
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 4.41 4.04 1.15 -

The Joint Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Graham Number Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.03 2.20 2.57 2.30 -

Competitive Comparison of The Joint's Graham Number

For the Medical Care Facilities subindustry, The Joint's Price-to-Graham-Number, along with its competitors' market caps and Price-to-Graham-Number data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


The Joint's Price-to-Graham-Number Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, The Joint's Price-to-Graham-Number distribution charts can be found below:

* The bar in red indicates where The Joint's Price-to-Graham-Number falls into.



The Joint Graham Number Calculation

Graham Number is a concept based on Ben Graham's conservative valuation of companies.

The Joint's Graham Number for the fiscal year that ended in Dec. 2023 is calculated as

Graham Number
=sqrt of (22.5* Tangible Book per Share *EPS without NRI)
=sqrt of (22.5*0.839*-0.521)
=N/A

The Joint's Graham Number for the quarter that ended in Dec. 2023 is calculated as

Graham Number
=sqrt of (22.5*Tangible Book per Share*EPS without NRI (TTM))
=sqrt of (22.5*0.839*-0.523)
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


The Joint  (NAS:JYNT) Graham Number Explanation

Ben Graham actually did not publish a formula like this. But he wrote in The Intelligent Investor (1948 version) regarding to the criteria for purchases:

Current price should not be more than 15 times average earnings of the past three years.

Current price should not be more than 1.5 times the book value last reported. However, a multiplier of earnings below 15 could justify a correspondingly higher multiplier of assets. As a rule of thumb we suggest that the product of the multiplier times the ratio of price to book value should not exceed 22.5. (This figure corresponds to 15 times earnings and 1.5 times book value. It would admit an issue selling at only 9 times earnings and 2.5 times asset value, etc.)

Unlike valuation methods such as DCF or Discounted Earnings, the Graham number does not take growth into the valuation. Unlike the valuation methods based on book value alone, it takes into account the earnings power. Therefore, the Graham Number is a combination of asset valuation and earnings power valuation.

In general, the Graham number is a very conservative way of valuing a stock. It cannot be applied to companies with negative book values.

The Joint's Price to Graham number Ratio for today is calculated as

Price to Graham number=Share Price (Today)/Graham number (Q: Dec. 2023 )
=12.23/N/A
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Please keep these in mind:

1. Graham Number does not take growth into account. Therefore it underestimates the values of the companies that have good earnings growth. We feel that if the earnings per share grows more than 10% a year, Graham Number underestimates the value.
2. Graham Number punishes the companies that have temporarily low earnings. Therefore, an average of earnings makes more sense in the calculation of Graham Number.
3. Graham Numbers underestimates companies that are light with book.


The Joint Graham Number Related Terms

Thank you for viewing the detailed overview of The Joint's Graham Number provided by GuruFocus.com. Please click on the following links to see related term pages.


The Joint (The Joint) Business Description

Traded in Other Exchanges
N/A
Address
16767 North Perimeter Drive, Suite 110, Scottsdale, AZ, USA, 85260
The Joint Corp develops, owns, operates, supports, and manages chiropractic clinics through direct ownership, management arrangements, franchising, and the sale of regional developer rights throughout the United States. The doctors of chiropractic develop personalized treatment plans to relieve patients' pain and deliver ongoing preventative care. The Company has two operating business segments; the Corporate Clinics segment is comprised of the operating activities of the company-owned or managed clinics, and The Franchise Operations segment is comprised of the operating activities of the franchise business unit. The company generates maximum revenue from the Corporate clinic's segment.
Executives
Bandera Partners Llc 10 percent owner 50 BROAD STREET, SUITE 1820, NEW YORK NY 10004
Peter D Holt officer: Chief Operating Officer 16767 N. PERIMETER DR., SUITE 240, SCOTTSDALE AZ 85260
Jake Singleton officer: Chief Financial Officer 16767 NORTH PERIMETER DRIVE, SUITE 240, SCOTTSDALE AZ 85260
Ronald V Davella director 2600 E SOUTHLAKE BLVD., STE 120-359, SOUTHLAKE TX 76092
Glenn J Krevlin 10 percent owner 600 FIFTH AVE, 11TH FL, NEW YORK NY 10020
Matthew E Rubel director 3231 SE SIXTH AVENUE, TOPEKA KS 66607
Gregory Bylinsky 10 percent owner C/O BANDERA PARTNERS LLC, 50 BROAD STREET, SUITE 1820, NEW YORK NY 10004
Jefferson Gramm 10 percent owner C/O BANDERA PARTNERS LLC, 50 BROAD STREET, SUITE 1820, NEW YORK NY 10004
Amos James H. Jr director 16767 N. PERIMETER DR., STE. 240, SCOTTSDALE AZ 85260
John P Meloun officer: Chief Financial Officer 16767 N. PERIMETER DR., STE. 240, SCOTTSDALE AZ 85260
Abe Hong director 16767 NORTH PERIMETER DRIVE, SUITE 240, SCOTTSDALE AZ 85260
Glenhill Advisors Llc 10 percent owner 600 FIFTH AVE, 11TH FL, NEW YORK NY 10020
Suzanne M Decker director 16767 NORTH PERIMETER DRIVE, SUITE 240, SCOTTSDALE AZ 85260
Bret Sanders director 16767 N. PERIMETER DR., STE. 240, SCOTTSDALE AZ 85260
David M Orwasher officer: President and COO 242 W 36TH ST, NEW YORK NY 10018